Alerts will be sent to your verified email
Verify Email
VENUSREM
|
Venus Remedies
|
Bharat Parenterals
|
Gufic Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.75 % | 16.48 % | 26.14 % |
|
5yr average Equity Multiplier
|
1.64 | 1.56 | 2.82 |
|
5yr Average Asset Turnover Ratio
|
0.78 | 1.12 | 1.1 |
|
5yr Avg Net Profit Margin
|
2.2 % | 9.36 % | 9.03 % |
|
Price to Book
|
0.93 | 5.09 | 8.18 |
|
P/E
|
15.1 | 34.38 | 37.96 |
|
5yr Avg Cash Conversion Cycle
|
62.86 Days | 72.73 Days | -18.02 Days |
|
Inventory Days
|
110.85 Days | 36.63 Days | 77.22 Days |
|
Days Receivable
|
37.87 Days | 106.98 Days | 81.36 Days |
|
Days Payable
|
50.32 Days | 87.71 Days | 175.58 Days |
|
5yr Average Interest Coverage Ratio
|
42.3 | 30.62 | 10.3 |
|
5yr Avg ROCE
|
5.53 % | 23.26 % | 33.27 % |
|
5yr Avg Operating Profit Margin
|
12.68 % | 16.78 % | 17.37 % |
|
5 yr average Debt to Equity
|
0.38 | 0.08 | 0.73 |
|
5yr CAGR Net Profit
|
n/a | 18.21 % | 29.43 % |
|
5yr Average Return on Assets
|
3.42 % | 10.57 % | 10.17 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.76 % | 73.27 % | 72.51 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
5.87 % | -1.15 % | 6.76 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -6.16 % |
|
Venus Remedies
|
Bharat Parenterals
|
Gufic Biosciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
